Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: WHL who wrote (2442)	5/5/1998 11:52:00 PM
From: westpacific	Respond to of 3725

I have been in and out of this stock over the past year and still hold a large position. IMAT was making moves earlier this year to do a study with a Statin drug manufacturer and a PBM to test the feasibility of bundling the scan with a drug treatment program for prevention and potential for costs savings to managed care players. This was purely rumor but may have some fact behind it, the benefit for the drug manufacturer is obvious, the benefit it IMAT also. The deal never happened, hope that this may still be ongoing. If this were to occur we could see a significant jump in price.